‘I am very excited’: Holocaust survivor looks forward to getting COVID-19 vaccine [unable to retrieve full-text content] Williams said she was diagnosed with multiple myeloma just days ago. It's a type of blood cancer that affects plasma cells. "My doctor said it would be …Published at Thu, 11 Feb 2021 04:36:56 +0000
Read More Joyce Evelyn (Sanborn) Witters [unable to retrieve full-text content] Joyce died in her home surrounded by family due to multiple myeloma cancer. She was 82 years old. Joyce was born in Oakland Ca., the third child of …Published at Thu, 11 Feb 2021 06:00:00 +0000
Read More
Global Castrate-resistant Prostate Cancer Market By Therapy, By Region, Industry Analysis and … New York, Feb. 10, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Castrate-resistant Prostate Cancer Market By Therapy, By Region, Industry Analysis and Forecast, 2020 – 2026” – https://www.reportlinker.com/p06021881/?utm_source=GNW The global market of CRPC is estimated to rise […]
Read More
Breakthroughs That Can Help Breast Cancer Patients Improve Quality Of Life Oncologists are increasingly understanding that a one-size-fits-all approach is not the best way to treat breast cancer. Many factors play a role in selecting the best treatment path, including the disease stage, tumour biology and of course the patient’s preferences. Image: Shutterstock Another important […]
Read More
Study reveals why Black men with prostate cancer have greater survival benefits from … Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment. A new Northwestern Medicine study discovered the reason appears to be an increase of a surprising type of immune cell in the tumor. The […]
Read More Actinium Announces Participation in BIO CEO & Investor Digital Conference NEW YORK, Feb. 10, 2021 /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium” or the “Company”) today announced that management will participate in the BIO CEO & Investor conference, which is being held digitally February 16 – 18, 2021. Members of Actinium’s executive team […]
Read More
FDA Clears Way for Clinical Trial of HDP-101 Heidelberg Pharma has been cleared in the U.S. to begin a clinical trial testing its investigational therapy HDP-101 for the treatment of multiple myeloma. The U.S. Food and Drug Administration (FDA) allowed the start of a Phase 1/2a trial following the submission of an investigational new drug […]
Read More
2018 Treatment Algorithm for Multiple Myeloma Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions 2018 Treatment Algorithm for Multiple Myeloma Presented by S. Vincent Rajkumar, MD Friday, December 8, 2017 Atlanta, Georgia Friday Satellite Symposium preceding the 59th ASH Annual Meeting & Exposition. This activity is supported by educational grants from […]
Read More
Rhizen’s cancer drug Umbralisib gets USFDA nod: Alembic Pharma – The Economic Times Alembic Pharma on Tuesday said its associate company Rhizen Pharmaceuticals AG’s product Umbralisib, which was licensed to TG Therapeutics, has received approval from the US health regulator the drug for the treatment of certain forms of cancer. In a regulatory filing, Alembic […]
Read More
Alembic’s affiliate Rhizen bags US regulator nod for oral cancer drug In what could further boost Alembic Pharmaceutical’s oncology business, its co-owned clinical-stage biopharmaceutical firm Rhizen Pharmaceuticals AG has bagged US Food and Drug Administration (USFDA) nod for an oral drug indicated in treating lymphoma. Umbralisib is indicated for treatment of adult patients with relapsed […]
Read More